Is perinatal dexamethasone treatment safe in preterm infants?
Baud
O
O
Laboratoire de neurologie du développement, INSERM E9935, Hôpital Robert Debré, Assistance Publique-Hôpitaux de Paris, 48 Boulevard Sérurier, F-75019 Paris, France.
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001623:Betamethasone / Q000008:administration & dosage / Q000627:therapeutic use; D003907:Dexamethasone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000517:prevention & control*; D011181:Postnatal Care; D011247:Pregnancy; D011295:Prenatal Care
D000893:Anti-Inflammatory Agents; D003907:Dexamethasone; D001623:Betamethasone